Pathophysiology and Management of Cardiovascular Manifestations in Marfan and Loeys–Dietz Syndromes
- 1 January 2016
- journal article
- review article
- Published by International Heart Journal (Japanese Heart Journal) in International Heart Journal
- Vol. 57 (3) , 271-277
Abstract
Marfan syndrome (MFS) is an autosomal dominant heritable disorder of connective tissue that affects the cardiovascular, skeletal, ocular, pulmonary, and nervous systems and is usually caused by mutations in the FBN1 gene, which encodes fibrillin-1. MFS is traditionally considered to result from the structural weakness of connective tissue. However, recent investigations on molecular mechanisms indicate that increased transforming growth factor-β (TGF-β) activity plays a crucial role in the pathogenesis of MFS and related disorders, such as Loeys-Dietz syndrome (LDS), which is caused by mutation in TGF-β signaling-related genes. In addition, recent studies show that angiotensin II type 1 receptor (AT1R) signaling enhances cardiovascular pathologies in MFS, and the angiotensin II receptor blocker losartan has the potential to inhibit aortic aneurysm formation. However, the relationship between TGF-β and AT1R signaling pathways remains poorly characterized. In this review, we discuss the recent studies on the molecular mechanisms underlying cardiovascular manifestations of MFS and LDS and the ensuing strategies for management.Keywords
This publication has 79 references indexed in Scilit:
- Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysmNature Genetics, 2012
- Modulation of noncanonical TGF-β signaling prevents cleft palate in Tgfbr2 mutant miceJournal of Clinical Investigation, 2012
- Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK AntagonismScience, 2011
- Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome MiceScience, 2011
- β-Arrestin–Biased Agonism of the Angiotensin Receptor Induced by Mechanical StressScience Signaling, 2010
- Circulating Transforming Growth Factor-β in Marfan SyndromeCirculation, 2009
- Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysmsThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Effect of Mutation Type and Location on Clinical Outcome in 1,013 Probands with Marfan Syndrome or Related Phenotypes and FBN1 Mutations: An International StudyThe American Journal of Human Genetics, 2007
- Epithelial and ectomesenchymal role of the type I TGF-β receptor ALK5 during facial morphogenesis and palatal fusionDevelopmental Biology, 2006
- Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan SyndromeScience, 2006